Emerging Infectious Diseases and Health Emergencies: Estimating the prevalence of the bacteria pneumonia and COVID-19 diseases, and quantifying COVID-19 impacts on vulnerable population such as opioid overdose for effective monitoring and planning.

新发传染病和突发卫生事件：估计细菌性肺炎和 COVID-19 疾病的患病率，并量化 COVID-19 对弱势群体的影响，例如阿片类药物过量，以进行有效的监测和规划。

• 批准号: 491199
• 负责人: OLOBATUYI KEHINDE
• 金额: $ 19.67万
• 依托单位: University of Victoria (British Columbia)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-05-01 至 2026-05-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=491199&lang=en
• 关键词: Bacteria Pneumonia; Covid-19 Disease Prevalence; Covid-19 Impacts On The Vulnerable Population; Opioid Overdose; Streptococcus Pneumococcal Serotype

My research aims to assist the Canadian government in combating emerging infectious diseases and protecting vulnerable populations. My research will focus on two infectious diseases, COVID-19 and bacterial pneumonia, and their impact on vulnerable populat

我的研究旨在协助加拿大政府抗击新出现的传染病和保护弱势群体。我的研究将集中在两种传染病，COVID-19和细菌性肺炎，以及它们对弱势群体的影响。